Cargando…

Advances in small molecule inhibitors for treatment of psoriasis

Detalles Bibliográficos
Autores principales:	Chen, Wen-Juan, Peng, Chen, Lu, Jia-Jing, Ding, Yang-Feng, Li, Xing-Zi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183699/ https://www.ncbi.nlm.nih.gov/pubmed/34075903 http://dx.doi.org/10.1097/CM9.0000000000001351

Ejemplares similares

Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis
por: Xia, Rui Yuan, et al.
Publicado: (2023)

Recent Advances in Small Molecule Inhibitors for the Treatment of Osteoarthritis
por: Lin, Jianjing, et al.
Publicado: (2023)

Clinical features of Chinese psoriatic patients for early referral of arthritis using psoriasis epidemiology screening tool: A cross-sectional analysis from the registry database of Chinese Psoriasis Standardized Diagnosis and Treatment Center
por: Xia, Ping, et al.
Publicado: (2023)

Accuracy of dermoscopic and reflectance confocal microscopic criteria for diagnosis of psoriasis
por: Wang, Zi-Yi, et al.
Publicado: (2020)

Updates in psoriasis diagnosis and treatment status in China: results from the National Psoriasis Center Registry
por: Yang, Zhihui, et al.
Publicado: (2023)

Successful treatment of generalized pustular psoriasis with secukinumab: a report of two cases
por: Sun, Zhi-Lin, et al.
Publicado: (2020)

Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules
por: Bellinato, Francesco, et al.
Publicado: (2021)

Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis
por: Huang, He, et al.
Publicado: (2023)

Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China
por: Zhao, Liang, et al.
Publicado: (2021)

Real-world investigation of the efficacy and safety of secukinumab for psoriasis treatment in a Chinese population
por: Zeng, Jing-Xin, et al.
Publicado: (2021)

Pseudoainhum in Psoriasis
por: Kumar, Pradeep, et al.
Publicado: (2012)

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
por: Jiang, Yuxiong, et al.
Publicado: (2023)

Geographic Tongue as an Indicator of Disease Activity to Determine Treatment Goals in Generalised Pustular Psoriasis
por: Wu, Shou-En, et al.
Publicado: (2023)

Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer
por: Li, Wen-Qian, et al.
Publicado: (2020)

Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis
por: Caputo, Valerio, et al.
Publicado: (2021)

Value of multimodality imaging in diagnosing primary small cell carcinoma of breast
por: Guo, Zhuan-Zhuan, et al.
Publicado: (2019)

Ixekizumab for the treatment of erythrodermic psoriasis triggered by durvalumabtremelimumab in a cancer patient
por: Vinaixa Aranzazu, Arrieta, et al.
Publicado: (2021)

Recurrent generalized pustular psoriasis possibly triggered by apremilast
por: Wang, Wen-Ming, et al.
Publicado: (2020)

Coexistence of acne inversa with psoriasis and Dowling-Degos disease harboring impaired PSENEN-Notch signaling
por: Xiao, Xue-Min, et al.
Publicado: (2020)

Beating Palmoplantar Psoriasis Away
por: D’Souza, Paschal V
Publicado: (2012)

Serum Omentin-1 in Psoriasis
por: Bakry, Ola Ahmed, et al.
Publicado: (2018)

Erythrodermic Psoriasis after Rituximab Treatment in a Patient with Autoimmune Hemolytic Anemia
por: Koumaki, Dimitra, et al.
Publicado: (2021)

Validating the Chinese version of the psoriasis epidemiology screening tool and early arthritis for psoriatic patients questionnaires
por: Lu, Chao-Fan, et al.
Publicado: (2021)

Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
por: Bai, Wen, et al.
Publicado: (2023)

Multidisciplinary treatment in pulmonary metastasis of a mesorectal angiosarcoma achieving complete remission
por: Zhou, Ding, et al.
Publicado: (2020)

Goa Powder as a Remedy in Psoriasis
por: Ram, Sobha
Publicado: (1878)

Goa Powder as a Remedy in Psoriasis
por: Ringer, Theobald
Publicado: (1877)

A Case of Psoriasis Encircled by Porokeratosis
por: Podder, Indrashis, et al.
Publicado: (2016)

Online decision aid for patients with psoriasis
por: van der Kraaij, G.E., et al.
Publicado: (2021)

Oral Psoriasis – A Rare Entity
por: Lobo, Carol, et al.
Publicado: (2022)

Development of clinical diagnostic criteria for plaque psoriasis in children: an electronic Delphi consensus study with the International Psoriasis Council
por: Burden‐Teh, E., et al.
Publicado: (2019)

Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus
por: Wang, Wen-Ming, et al.
Publicado: (2018)

The top 10 research priorities for psoriasis in the U.K.: results of a James Lind Alliance psoriasis Priority Setting Partnership
por: Majeed‐Ariss, R., et al.
Publicado: (2019)

A rapid access clinic for psoriasis: first experiences
por: Reid, Claire, et al.
Publicado: (2022)

Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors
por: Kim, Hyeon Jin, et al.
Publicado: (2021)

Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges
por: Kamal, Monica A., et al.
Publicado: (2022)

Survivin Small Molecules Inhibitors: Recent Advances and Challenges
por: Albadari, Najah, et al.
Publicado: (2023)

Carbonic Anhydrase Inhibitors: A New Dawn for the Treatment of Obstructive Sleep Apnea
por: Chen, Riken, et al.
Publicado: (2022)

Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation
por: Mao, Shiqi, et al.
Publicado: (2023)

Recent advances in the discovery of small-molecule inhibitors of HIV-1 integrase
por: Choi, Eungi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_olfdlgm8pufkr6h29vrlufjnov